Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB26FATXX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,147
Award facts
- Contract value 100% obligated
- $14,146.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Orencia ClickJect 125 mg/mL. This firm fixed-price delivery order, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The place of performance is listed as Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions the contractor as a regional prime vendor supplying a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for military medical facilities globally.
Quick answers
Who was awarded contract SPE2DB26FATXX?
SPE2DB26FATXX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FATXX worth?
The government has obligated $14,147 on SPE2DB26FATXX.
Is contract SPE2DB26FATXX an order under another contract?
Yes. SPE2DB26FATXX is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATXX competed?
The extent of competition for SPE2DB26FATXX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award